» Articles » PMID: 39051221

Gut Microbiome Interactions with Oxidative Stress: Mechanisms and Consequences for Health

Overview
Journal Pathophysiology
Publisher MDPI
Specialty Pathology
Date 2024 Jul 25
PMID 39051221
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding how gut flora interacts with oxidative stress has been the subject of significant research in recent years. There is much evidence demonstrating the existence of the microbiome-oxidative stress interaction. However, the biochemical basis of this interaction is still unclear. In this narrative review, possible pathways of the gut microbiota and oxidative stress interaction are presented, among which genetic underpinnings play an important role. Trimethylamine-N-oxide, mitochondria, short-chain fatty acids, and melatonin also appear to play roles. Moreover, the relationship between oxidative stress and the gut microbiome in obesity, metabolic syndrome, chronic ethanol consumption, dietary supplements, and medications is considered. An investigation of the correlation between bacterial community features and OS parameter changes under normal and pathological conditions might provide information for the determination of new research methods. Furthermore, such research could contribute to establishing a foundation for determining the linkers in the microbiome-OS association.

Citing Articles

The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies.

Krawczyk A, Sladowska G, Strzalka-Mrozik B Cancers (Basel). 2025; 17(5).

PMID: 40075568 PMC: 11899293. DOI: 10.3390/cancers17050719.


Melatonin from Plants: Going Beyond Traditional Central Nervous System Targeting-A Comprehensive Review of Its Unusual Health Benefits.

Fornari Laurindo L, Simili O, Cressoni Araujo A, Landgraf Guiguer E, Direito R, Valenti V Biology (Basel). 2025; 14(2).

PMID: 40001911 PMC: 11851571. DOI: 10.3390/biology14020143.


Therapeutic Efficacy and Underlying Mechanisms of a Mannoglucan from Mycelium on Dextran Sulfate Sodium-Induced Inflammatory Bowel Disease in Mice: Modulation of the Intestinal Barrier, Oxidative Stress and Gut Microbiota.

Ni W, Li Y, Feng J, Liu B, Yuan H, Tai G Int J Mol Sci. 2024; 25(23).

PMID: 39684811 PMC: 11642296. DOI: 10.3390/ijms252313100.


Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes.

Iatcu O, Hamamah S, Covasa M Nutrients. 2024; 16(20).

PMID: 39458444 PMC: 11510484. DOI: 10.3390/nu16203447.

References
1.
Ghosh T, Shanahan F, OToole P . The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol. 2022; 19(9):565-584. PMC: 9035980. DOI: 10.1038/s41575-022-00605-x. View

2.
Xu F, Fu Y, Sun T, Jiang Z, Miao Z, Shuai M . The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases. Microbiome. 2020; 8(1):145. PMC: 7545574. DOI: 10.1186/s40168-020-00923-9. View

3.
Paul P, Kaul R, Abdellatif B, Arabi M, Upadhyay R, Saliba R . The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review. Front Nutr. 2022; 9:906243. PMC: 9197462. DOI: 10.3389/fnut.2022.906243. View

4.
Mei Q, Hu J, Huang Z, Fan J, Huang C, Lu Y . Pretreatment with chitosan oligosaccharides attenuate experimental severe acute pancreatitis via inhibiting oxidative stress and modulating intestinal homeostasis. Acta Pharmacol Sin. 2021; 42(6):942-953. PMC: 8149410. DOI: 10.1038/s41401-020-00581-5. View

5.
Zhu T, Wang L, Feng Y, Sun G, Sun X . Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke. Oxid Med Cell Longev. 2021; 2021:8868941. PMC: 7984881. DOI: 10.1155/2021/8868941. View